Troubled Overseas Drugmakers Get Free Pass in Coronavirus Crisis

Published April 9, 2020

U.S. regulators are allowing overseas pharmaceutical plants with checkered safety and quality records to make prescription drugs for Americans in an effort to fill supply gaps caused by the coronavirus pandemic.

Related Stories